
Estimating the AUC for Vancomycin Using Non Trapezoidal Equations
In the second part of our conversation, Abdulwhab Shremo Msdi, PharmD, discusses using this methodology.
In the first part of the interview with Msdi, he discussed AUC-based monitoring for vancomycin and its adoption by institutions and its value in dosing. (See the article below.)
Read more:
In this segment, Msdi talks about using a unique approach that estimates the AUC for vancomycin using non trapezoidal equations. He says the equations are not novel but rather uncommon and he discovered them during his fellowship.
“I think it's an attention issue—not complexity—because they are not very complex to do, but there is just not much published for us pharmacists to see how to use them," Msdi said.
He also likes this approach as it helps describe drug kinetics.
Back in the fall, Msdi coauthored an article on the topic and provided information on this approach. (See the article below.)
Read More:
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.